Clusterin is associated with spontaneous breast cancer in TA2 mice

FEBS Letters

Volumn 581, Issue 17, 2007, Pages 3277-3282

  Sun, Baocun ^a,b   Zhang, Shiwu ^a,b   Zhang, Danfang ^a,b   Liu, Yanqing ^a   Li, Yan ^a   Rong, Zhe ^a   Zhu, Yue ^a   Jia, Xinghong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Electrospray ion trap mass spectrometry; n Clusterin; Spontaneous breast cancer; Two dimensional electrophoresis

Indexed keywords

CLUSTERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER MODEL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TWO DIMENSIONAL ELECTROPHORESIS;

ANIMALS; CELL NUCLEUS; CLUSTERIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, MUTANT STRAINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

MUS;

EID: 34250796204     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.06.021     Document Type: Article

References (34)

1. Qingsheng W., Xishan H., Shibei Y., Zeyu G., and Kexin C. Incidence and mortality of Malignant cancer in Tianjin, 1993-1997. Bulletin of Chinese Cancer 9 (2000) 550-551
2. Janssens J.P., Verlinden I., Gungor N., Raus J., and Michiels L. Protein biomarkers for breast cancer prevention. Eur. J. Cancer Prev. 13 (2004) 307-317
3. Luo Y., Zhang J., Liu Y., Shaw A.C., Wang X., Wu S., Zeng X., Chen J., Gao Y., and Zheng D. Comparative proteome analysis of breast cancer and normal breast. Mol. Biotechnol. 29 (2005) 233-244
4. Petricoin E.E., Paweletz C.P., and Liotta L.A. Clinical applications of proteomics: proteomic pattern diagnostics. J. Mammary Gland Biol. Neoplasia 7 (2002) 433-440
5. Huazhang H. Spontanous breast cancer of TA2. Tianjin Med. J. 6 (1982) 345
6. Bingshui L., Yi L., Hua L., Yuying Z., and Jiayong L. The inbred TA2 mice and their biological traits. Shanghai Xu Mo Shou Yi Tong Xun 2 (1982) 1-5
7. Penggen G., Yun S., Youchen G., Xichang L., Jixin W., and Youhui Z. A murine model of mammary endocaicinoma with high rate of spontaneous metastases in the lungs. Acta Acad. Med. Sci. 16 (1994) 147-152
8. Ong S.E., Foster L.J., and Mann M. Mass spectrometric-based approached in quantitative proteomics. Methods 29 (2003) 124-130
9. Gorg A., Obermaier C., Boguth G., Harder A., Scheibe B., Wildgruber R., and Weiss W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21 (2000) 1037-1053
10. Goufman E.I., Moshkovskii S.A., Tikhonova O.V., Lokhov P.G., Zgoda V.G., Serebryakova M.V., Toropygin I.Y., Vlasova M.A., Safarova M.R., Makarov O.V., and Archakov A.I. Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions. Biochemistry (Mosc) 71 (2006) 354-360
11. Kujiraoka T., Takano M., and Hattori H. Apolipoprotein J (APO J). Nippon Rinsho 62 (2004) 117-120
12. Criswell T., Klokov D., Beman M., Lavik J.P., and Boothman D.A. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein. Cancer Biol. Ther. 2 (2003) 372-380
13. Shannan B., Seifert M., Leskov K., Willis J., Boothman D., Tilgen W., and Reichrath J. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ. 13 (2006) 12-19
14. Lee C., Janulis L., Ilio K., Shah A., Park I., Kim S., Cryns V., Pins M., and Bergan R. In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator. Prostate Suppl. 9 (1995) 21-24
15. Pajak B., and Orzechowski A. Clusterin: the missing link in the calcium-dependent resistance of cancer cells to apoptogenic stimuli. Postepy Hig. Med. Dosw. (Online) 60 (2006) 45-51
16. Shannan B., Seifert M., Boothman D.A., Tilgen W., and Reichrath J. Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control. J. Mol. Histol. 37 (2006) 183-188
17. Tschopp J., and French L.E. Clusterin: modulation of complement function. Clin. Exp. Immunol. 86 (2000) 236-239
18. So A., Sinnemann S., Huntsman D., Fazli L., and Gleave M. Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo. Mol. Cancer Ther. 4 (2005) 1837-1849
19. Pucci S., Bonanno E., Pichiorri F., Angeloni C., and Spagnoli L.G. Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 23 (2004) 2298-2304
20. Caccamo A.E., Scaltriti M., Caporali A., D'Arca D., Scorcioni F., Candiano G., Mangiola M., and Bettuzzi S. Nuclear translocation of a clusterin isoform is associated with induction of anoikis in SV40-immortalized human prostate epithelial cells. Ann. NY Acad. Sci. 1010 (2003) 514-519
21. Nakamura E., Abreu-e-Lima P., Awakura Y., Inoue T., Kamoto T., Ogawa O., Kotani H., Manabe T., Zhang G.J., Kondo K., Nose V., and Kaelin Jr. W.G. Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein. Am. J. Pathol. 168 (2006) 574-584
22. Redondo M., Villar E., Torres-Munoz J., Tellez T., Morell M., and Petito C.K. Overexpression of clusterin in human breast carcinoma. Am. J. Pathol. 157 (2000) 393-399
23. Shannan B., Seifert M., Leskov K., Boothman D., Pfohler C., Tilgen W., and Reichrath J. Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro. Anticancer Res. 26 (2006) 2707-2716
24. Tejskal D., and Fiala R.R. Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer. Neoplasma 53 (2006) 343-346
25. Okano T., Kondo T., Kakisaka T., Fujii K., Yamada M., Kato H., Nishimura T., Gemma A., Kudoh S., and Hirohashi S. Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. Proteomics 6 (2006) 3938-3948
26. Chen W., Xie D., Luo J.H., Wang C.X., Tao Y., Zheng K.L., and Mei H. The detection of protein expression of clusterin and Ki-67 and the status of cell apoptosis in bladder transitional cell carcinoma. Zhonghua Wai Ke Za Zhi 44 (2006) 111-114
27. Redondo M., Esteban F., Gonzalez-Moles M.A., Delgado-Rodriguez M., Nevado M., Torres-Munoz J.E., Tellez T., Villar E., Morell M., and Petito C.K. Expression of the antiapoptotic proteins clusterin and bcl-2 in laryngeal squamous cell carcinomas. Tumour Biol. 27 (2006) 195-200
28. Busam K.J., Kucukgol D., Eastlake-Wade S., Frosina D., Delgado R., and Jungbluth A.A. Clusterin expression in primary and metastatic melanoma. J. Cutan. Pathol. 33 (2006) 619-623
29. Jackson J.K., Gleave M.E., Gleave J., and Burt H.M. The inhibition of angiogenesis by antisense oligonucleotides to clusterin. Angiogenesis 8 (2005) 229-238
30. Gleave M., and Miyake H. Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer. World J. Urol. 23 (2005) 38-46
31. Seol M.B., Bong J.J., and Baik M. Expression profiles of apoptosis genes in mammary epithelial cells. Mol. Cells 20 (2005) 97-104
32. Zhang H., Kim J.K., Edwards C.A., Xu Z., Taichman R., and Wang C.Y. Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 7 (2005) 909-915
33. Rodriguez-Pineiro A.M., de. La. Cadena M.P., Lopez-Saco A., and Rodriguez-Berrocal F.J. Differential expression of serum clusterin isoforms in colorectal cancer. Mol. Cell Proteomics 5 (2006) 1647-1657
34. Xie D., Sham J.S., Zeng W.F., Che L.H., Zhang M., Wu H.X., Lin H.L., Wen J.M., Lau S.H., Hu L., and Guan X.Y. Oncogenic role of clusterin overexpression in multistage colorectal tumorigenesis and progression. World J. Gastroenterol. 11 (2005) 3285-3289